Journal
ONCOIMMUNOLOGY
Volume 2, Issue 12, Pages -Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/onci.27058
Keywords
anticancer vaccines; immunotherapy; metronomic chemotherapy; low-dose chemotherapy; lymphoma
Categories
Ask authors/readers for more resources
Therapeutic vaccination is regarded as a promising strategy against multiple hematological malignancies including lymphoma. However, this approach alone possesses limited potential for the treatment of established tumors. As several anticancer regimens relies on the combination of multiple drugs, it is reasonable to predict that also cancer vaccination will be most effective in the context of multimodal approaches. In particular, low-dose or metronomic chemotherapy could be coupled to anticancer vaccines to improve the efficacy of this immunotherapeutic interventions. This review summarizes recent findings in support of the use of anticancer vaccines combined with low-dose or metronomic chemotherapy for the treatment and management of lymphoid malignancies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available